Sign In
Buy TMDX
$71.37
+1.68 (+2.41%)
At Close: Jun 04, 2026
Block, MasTec, Universal Display And Some Other Big Stocks Moving Higher On Friday
03:26pm, Friday, 04'th Nov 2022 Benzinga
U.S. stocks traded higher, with the Dow Jones gaining more than 400 points on Friday. Here are some big stocks recording gains in today’s session.
Willdan Group, Inc. (NASDAQ: WLDN) surged 27.6% to
TransMedics (TMDX) Reports Q3 Loss, Tops Revenue Estimates
08:20pm, Thursday, 03'rd Nov 2022
TransMedics (TMDX) delivered earnings and revenue surprises of 37.50% and 35.44%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Teleflex (TFX) Surpasses Q3 Earnings Estimates
11:55am, Thursday, 27'th Oct 2022 Zacks Investment Research
Teleflex (TFX) delivered earnings and revenue surprises of 5.48% and 0.65%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
TransMedics Remains A Buy Heading Into Q3 Earnings
06:01pm, Thursday, 20'th Oct 2022
We advocate that TransMedics Group remains a speculative buy in the current market rout. Profitability and earnings trends continue to push north and serve as solid fundamental momentum looking ahead.
TransMedics: Game Changer Technology Will Boost Revenue Growth
08:47am, Thursday, 20'th Oct 2022
TransMedics is a long-term revenue growth story in organ transplant procedures. The company's technology is seeing smooth adoption replacing the current standard of care.
5 Analysts Have This to Say About TransMedics Group
05:06pm, Tuesday, 11'th Oct 2022 Benzinga
Analysts have provided the following ratings for TransMedics Group (NASDAQ:TMDX) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
0
3
2
0
The Zacks Analyst Blog Highlights TransMedics, PROCEPT BioRobotics and Sensus Healthcare
02:15pm, Tuesday, 04'th Oct 2022 Zacks Investment Research
TransMedics, PROCEPT BioRobotics and Sensus Healthcare are part of the Zacks top Analyst Blog Highlights.
3 Resilient Medical Stocks to Watch as Rate Hikes Continue
01:16pm, Monday, 03'rd Oct 2022 Zacks Investment Research
Here we discuss three Medical-Instruments stocks - TMDX, PRCT & SRTS - that continued to grow in the first nine months of 2022 even though three Fed rate hikes dragged broader indices down.
TransMedics to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
04:05pm, Monday, 29'th Aug 2022
ANDOVER, Mass. , Aug. 29, 2022 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-
TransMedics Is A Buy Following Q2 FY22 Earnings Upside
10:14am, Wednesday, 03'rd Aug 2022
TransMedics came in with another solid quarterly performance with upside in revenue versus consensus. The company is at an inflection point posting a record quarter in terms of sales and gross margin
Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2022
02:20pm, Tuesday, 02'nd Aug 2022 Benzinga
Upgrades
For Transocean Ltd (NYSE:RIG), Capital One upgraded the previous rating of Equal-Weight to Overweight. Transocean earned $0.10 in the second quarter, compared to $0.18 in the year-ago quarter
TransMedics Group, Inc. (TMDX) CEO Waleed Hassanein on Q2 2022 Results - Earnings Call Transcript
12:37am, Tuesday, 02'nd Aug 2022
Start Time: 16:30 January 1, 0000 5:16 PM ET TransMedics Group, Inc. (NASDAQ:TMDX ) Q2 2022 Earnings Conference Call August 01, 2022, 16:30 PM ET Company Participants Waleed Hassanein - President and
TransMedics (TMDX) Reports Q2 Loss, Tops Revenue Estimates
10:15pm, Monday, 01'st Aug 2022 Zacks Investment Research
TransMedics (TMDX) delivered earnings and revenue surprises of -28.13% and 26.21%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
TransMedics (TMDX) Reports Q2 Loss, Tops Revenue Estimates
07:23pm, Monday, 01'st Aug 2022
TransMedics (TMDX) delivered earnings and revenue surprises of -28.13% and 26.21%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Bear Market Winners: 3 Healthcare Stocks That Have Soared More Than 30% This Year
02:45pm, Thursday, 14'th Jul 2022 The Motley Fool
Have these scorching-hot stocks peaked, or could there still be more gains ahead for investors who buy today?
